RESUMO
Resumen Infection by SARS-CoV-2 virus is not solely limited to the common clinical presentation of acute respiratory distress syndrome, mainly because a wide spectrum of clinical manifestation has been observed. These presentations include, but are not limited to, neurological, cardiovascular, throm- boembolic, hematologic, and autoimmune presentations. Within this wide spectrum, cases of autoimmune hemolytic anemia due to SARS-CoV-2 infection are rising. This is why primary care physicians should be ready to identify this clinical entity appropriately.
Abstract Infection by SARS-CoV-2 virus is not solely limited to the common clinical presentation of acute respiratory distress syndrome, mainly because a wide spectrum of clinical manifestation has been observed. These presentations include, but are not limited to, neurological, cardiovascular, throm- boembolic, hematologic, and autoimmune presentations. Within this wide spectrum, cases of autoimmune hemolytic anemia due to SARS-CoV-2 infection are rising. This is why primary care physicians should be ready to identify this clinical entity appropriately.
RESUMO
El objetivo del presente trabajo es la exposición de lo que se considera el primer caso de peritonitis en un paciente con diálisis peritoneal continua ambulatoria (DPCA) -por insuficiencia renal crónica terminal-causada por Serratia marcescens y tratado exitosamente con carbenicilina. Se trata de un bacilo gramnegativo, móvil, aerobio, miembro de la división Klebsiella-Enterobacter-Serratia, entre la familia enterobacteriaceae. La Serratia contrasta con otros bacilos enterobacteriaceos en que no es huésped habitual del tracto digestivo y se adquiere por contaminación iatrógena como manipulación genitourinaria, diálisis peritoneal, hemodialisis y punción lumbar. Su tratamiento antibiótico es difícil pues presenta gran resistencia medicamentosa por plásmidos